Ingredient or product comparison
Evidence Comparison by Route
Human clinical trials Multiple (skin aging, post-laser, collagen) None Human observational data Decades of cosmetic product use Community self-reports only Animal studies Wound healing models Lung fibrosis, emphysema, ACL repair, neuroprotection In vitro / cel
This source-based comparison does not add ratings or recommend a winner.
- Human clinical trials
- Multiple (skin aging, post-laser, collagen)
- None
- Human observational data
- Decades of cosmetic product use
- Community self-reports only
- Animal studies
- Wound healing models
- Lung fibrosis, emphysema, ACL repair, neuroprotection
- In vitro / cell culture
- Collagen synthesis, fibroblast activation
- Gene expression (4,000+ genes), anti-inflammatory
- Mechanism clarity
- High -- well-characterized skin depot effect
- Moderate -- systemic pathways mapped in animal models
- Dose-response data
- Established in human studies
- Established in animal models only
- The bottom line: topical GHK-Cu has human-grade evidence for skin outcomes. Injectable GHK-Cu has promising preclinical evidence for systemic outcomes, with community adoption running ahead of published clinical validation.